Biostorage Technologies, a provider of services for the bioscience industry, has expanded its offerings to include a suite of global sample-relocation services.
The addition of these services enhances the company's global logistics capabilities and allows clients to customise transportation of entire sample inventories and associated equipment.
At the centre of Biostorage Technologies' relocation services is Relofleet, said to be the first mobile unit created specifically for sample relocation.
The custom-made, 53ft trailer accommodates storage temperatures from ambient to -20C and is capable of transporting a multitude of biomaterial samples, including plasma, blood and tissue samples, as well as active, pharmaceutical ingredients and manufactured drug products.
Equipped with redundant generator systems, the unit also allows Biostorage Technologies to transport freezers, including liquid nitrogen and refrigerators - intact and running.
Biostorage Technologies' specialised team of global logistics experts can provide full-scale support through every phase of the transportation process, including point-to-point tracking, re-icing and real-time issue resolution.
The Relofleet service provides sample tracking along the transportation process, with a complete audit trail of sample movement from site to site.
Biostorage Technologies is also one of only a few biorepositories designated as a Certified Cargo Screening Facility (CCSF) by the US Transportation Security Administration.
This certification allows Biostorage Technologies to pre-screen shipments at its facility, thereby avoiding screening delays at the airport, which could lead to sample degradation.
Biostorage Technologies' processes, systems and technology platforms are validated to adhere to US Food and Drug Administration regulations, as well as US Department of Transportation and International Air Transport Association guidelines.
